Tag Archives: Birth control

Featured Stories

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Death in Those Taking Bactrim with ACE Inhibitors or ARBs

Sudden Death in Those Taking Bactrim Along with ACE Inhibitors or ARBs

Association between sudden death in those given Bactrim while already taking renin-angiotensin system blockers angiotensin receptor blockers (ARBs), heart medications.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Premarket Approval for Essure Birth Control Device Was Fraudulent, Patients Say

premarket-approval-Essure

Patients involved in the clinical trials conducted in connection with the premarket approval application (PMA) for the Essure birth control device say that patient records were altered to show favorable results despite patient reports of problems. The Food and Drug … Continue reading

Posted in Defective Medical Devices, Essure, Health Concerns | Tagged , , , , |

Legislation Introduced to Require FDA to Pull Essure Birth Control from Market

FDA to Pull Essure Birth Control from Market

U.S. Representative Michael Fitzpatrick of Pennsylvania has introduced a new bill that directs the Food and Drug Administration (FDA) to withdraw Bayer’s Essure birth control implant from the market. The safety of the implantable device—a permanent birth control method—has been … Continue reading

Posted in Defective Medical Devices, Essure, Health Concerns | Tagged , , , , |

FDA Convening Panel to Reconsider Safety of Essure Birth Control System

FDA Convening Panel to Reconsider Safety of Essure

On September 24, 2015, the Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee of the Food and Drug Administration (FDA) will meet to discuss the risks and benefits of Bayer HealthCare’s Essure birth control system. The panel … Continue reading

Posted in Defective Medical Devices, Health Concerns | Tagged , , , , |

In Light of Patient Complaints, FDA to Reconsider Safety of Essure Permanent Birth Control

FDA to Reconsider Safety of Essure Permanent Birth Control

The U.S. Food and Drug Administration (FDA) will be re-evaluating the safety of Essure following complaints from patients who say the permanent birth control device caused painful complications. Currently, it is the only approved permanent nonsurgical form of contraception on … Continue reading

Posted in Legal News | Tagged , , , , |

Thousands of Complaints Prompt FDA Panel Meeting about Essure Birth Control

Complaints Prompt FDA Panel Meeting about Essure

In response to more than 5,000 reports of adverse events and side effects of the Essure birth control implant, the Food and Drug Administration (FDA) has scheduled a hearing for September 24 to evaluate the safety and effectiveness device. The … Continue reading

Posted in Defective Medical Devices, Health Concerns | Tagged , , , , |

Study Links Newer Birth Control Pills to Increased Risk of Blood Clots

Newer Birth Control Pills to Increased Risk of Blood Clots

A study published in the BMJ, the online journal of the British Medical Association, adds to a growing body of evidence linking newer birth control pills to an increased risk of blood clots. Researchers found that women taking newer oral … Continue reading

Posted in Health Concerns, Legal News | Tagged , , , , |

Food and Drug Administration Issues Response to Petition for Removal of Essure Birth Control from Market

FDA Issues Response to Petition for Removal of Essure Birth Control from Market

Last week the Food and Drug Administration (FDA) responded to a petition demanding removal of Essure permanent birth control device from the market. The petition was signed by more than 2,100 women who are concerned about injuries and adverse effects … Continue reading

Posted in Defective Medical Devices, Health Concerns | Tagged , , , , |

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors. Hormonal contraceptives, which contain female sex hormones, are commonly prescribed in pill form. “The Pill” first … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , |

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

Birth Control Shot Depo-Provera may Increase HIV Risk

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection. The study was conducted by researchers at the University of California at Berkeley and published in The … Continue reading

Posted in Legal News | Tagged , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.